Actos vs. Januvia: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Actos and Januvia. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 138,614 people who take Actos and Januvia, and is updated regularly.
What is Actos?
Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,754 Actos users. Check the latest studies of Actos.
What is Januvia?
Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
138,614 people who take Actos and Januvia are studied.
Drugs being compared in this study:
- Januvia (sitagliptin phosphate)
- Actos (pioglitazone hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Actos:
- not at all: 2.64 %
- somewhat: 18.94 %
- moderate: 41.73 %
- high: 28.54 %
- very high: 8.15 %
Januvia:
- not at all: 3.86 %
- somewhat: 23.3 %
- moderate: 34.62 %
- high: 28.1 %
- very high: 10.12 %
Want to compare Actos with Januvia?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Actos:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Januvia:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on pioglitazone hydrochloride and sitagliptin phosphate (the active ingredients of Actos and Januvia, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zyrtec Allergy cause Diarrhea Aggravated? - 5 seconds ago
- Metastases To Bone and Purulence - 10 seconds ago
- Could Fluconazole cause Enterovirus Infection? - 19 seconds ago
- Could Zyban cause Abdominal Pain Upper? - 25 seconds ago
- Remicade and Suicidal Ideation for Women aged 50-59 - 30 seconds ago
- Remicade and Suicidal Thoughts for Women aged 50-59 - 31 seconds ago
- Could Bydureon Bcise cause Retching? - 31 seconds ago
- Incontinence and Itching - 58 seconds ago
- Infection and Hypocalcaemia - 59 seconds ago
- Could Zomig cause Intervertebral Disc Protrusion? - a minute ago